 In these studies, women treated with  TARGIT-IORT  during lumpectomy for breast cancer combined with whole breast radiotherapy had a significantly low mortality from non-breast-cancer causes, such as cardiovascular and lung complications, as well as other cancers compared with those who received whole breast radiotherapy.
<meaning-changed>  In these studies, women treated with  TARGIT-IORT  during lumpectomy for breast cancer combined with whole breast radiotherapy had a significantly low mortality from non-breast-cancer causes, such as cardiovascular and lung complications, as well as other cancers compared with those who received whole breast radiotherapy.
 In these studies, women treated with TARGIT-IORT to EBRT during lumpectomy for breast cancer combined with whole breast radiotherapy had a significantly low mortality from non-breast-cancer causes, such as cardiovascular and lung complications, as well as other cancers compared with those who received whole breast radiotherapy.